Development of SARS-CoV-2 replicons for the ancestral virus and variant of concern Delta for antiviral screening (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.10.11.511804
Publication URI: http://dx.doi.org/10.1101/2022.10.11.511804
Type: Preprint